Fractional carbon dioxide laser for treating hypertrophic scars: A systematic review of randomised trials

2021 ◽  
Author(s):  
Irma Bernadette Simbolong Sitohang ◽  
Sondang Aemilia P. Sirait ◽  
Fadhila Dea Safira
Keyword(s):  
Carbon Dioxide ◽  
Systematic Review ◽  
Carbon Dioxide Laser ◽  
Hypertrophic Scars ◽  
Randomised Trials ◽  
Fractional Carbon Dioxide Laser

scholarly journals Fractional Carbon Dioxide Laser in Treatment of Acne Scars

2015 ◽  
Vol 4 (1) ◽  
pp. 38-42 ◽  
Author(s):  
Andrej Petrov ◽  
Vesna Pljakovska
Keyword(s):  
Carbon Dioxide ◽  
Carbon Dioxide Laser ◽  
The Other ◽  
Hypertrophic Scars ◽  
Skin Damage ◽  
Acne Scars ◽  
The World ◽  
Fractional Carbon Dioxide Laser ◽  
Skin Healing ◽  
Residual Lesions

BACKGROUND: Scars appear as a result of skin damage during the process of the skin healing. There are two types of acne scars, depending on whether there is a loss or accumulation of collagen: atrophic and hypertrophic. In 80-90% it comes to scars with loss of collagen compared to smaller number of hypertrophic scars and keloids.AIM: The aim of the study was to determine efficiency and safety of fractional carbon dioxide laser in the treatment of acne scars.MATERIAL AND METHODS: The study was carried out in Acibadem Sistina Clinical Hospital, Skopje at the Department of Dermatovenerology, with a total of 40 patients treated with fractional carbon dioxide laser (Lutronic eCO2). The study included patients with residual acne scars of a different type.RESULTS: Comedogenic and papular acne in our material were proportionately presented in 50% of cases, while the other half were the more severe clinical forms of acne - pustular inflammatory acne and nodulocystic acne that leave residual lesions in the form of second, third and fourth grade of scars.CONCLUSION: The experiences of our work confirm the world experiences that the best result with this method is achieved in dotted ice pick or V-shaped acne scars.

The Efficacy of Combining Fractional Carbon Dioxide Laser With Verapamil Hydrochloride or 5-Fluorouracil in the Treatment of Hypertrophic Scars and Keloids

2019 ◽  
Vol 45 (4) ◽  
pp. 536-546 ◽  
Author(s):  
Hanan H. Sabry ◽  
Sherine H. Abdel Rahman ◽  
Mohamed S. Hussein ◽  
Rana R. Sanad ◽  
Taghreed A. Abd El Azez
Keyword(s):  
Carbon Dioxide ◽  
Carbon Dioxide Laser ◽  
Hypertrophic Scars ◽  
Verapamil Hydrochloride ◽  
Fractional Carbon Dioxide Laser

Treatment of hypertrophic scars and keloids by fractional carbon dioxide laser: a clinical, histological, and immunohistochemical study

2015 ◽  
Vol 31 (1) ◽  
pp. 9-18 ◽  
Author(s):  
O. A. Azzam ◽  
D. A. Bassiouny ◽  
M. S. El-Hawary ◽  
Z. M. El Maadawi ◽  
R. M. Sobhi ◽  
...  
Keyword(s):  
Carbon Dioxide ◽  
Carbon Dioxide Laser ◽  
Immunohistochemical Study ◽  
Hypertrophic Scars ◽  
Fractional Carbon Dioxide Laser

scholarly journals Carbon Dioxide Laser Vulvovaginal Rejuvenation: A Systematic Review

Cosmetics ◽  
2021 ◽  
Vol 8 (3) ◽  
pp. 56
Author(s):  
Tassahil Messas ◽  
Achraf Messas ◽  
George Kroumpouzos
Keyword(s):  
Carbon Dioxide ◽  
Systematic Review ◽  
Laser Therapy ◽  
Carbon Dioxide Laser ◽  
Invasive Treatment ◽  
Erbium:Yag Laser ◽  
Non Invasive ◽  
Level I ◽  
Carbon Dioxide Co2

Genitourinary syndrome of menopause (GSM) causes significant symptomatic aggravation that affects the quality of life (QoL). Vulvovaginal atrophy (VVA), the hallmark of GSM, is managed with topical non-hormonal therapy, including moisturizers and lubricants, and topical estrogen application. Patients not responding/being unsatisfied with previous local estrogen therapies are candidates for a noninvasive modality. Carbon dioxide (CO2) laser therapy, especially the fractionated type (FrCO2), has drawn considerable attention over the past two decades as a non-invasive treatment for GSM. This systematic review describes the accumulated evidence from 40 FrCO2 laser studies (3466 participants) in GSM/VVA. MEDLINE, Scopus and Cochrane databases were searched through April 2021. We analyze the effects of FrCO2 laser therapy on symptoms, sexual function, and QoL of patients with GSM/VVA. As shown in this review, FrCO2 laser therapy for GSM shows good efficacy and safety. This modality has the potential to advance female sexual wellness. Patient satisfaction was high in the studies included in this systematic review. However, there is a lack of level I evidence, and more randomized sham-controlled trials are required. Furthermore, several clinical questions, such as the number of sessions required that determine cost-effectiveness, should be addressed. Also, whether FrCO2 laser therapy may exert a synergistic effect with systemic and/or local hormonal/non-hormonal treatments, energy-based devices, and other modalities to treat GMS requires further investigation. Lastly, studies are required to compare FrCO2 laser therapy with other energy-based devices such as erbium:YAG laser and radiofrequency.

Sign in / Sign up

Export Citation Format

Share Document